The landscape of ROS1 fusion in patients with non-small cell lung cancer in China

被引:0
作者
Chen, M. [1 ]
Huang, D. [2 ]
She, X. [2 ]
Shen, X. [2 ]
Zhang, H. [2 ]
Luo, Z. [3 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 3, Dept Resp, Chongqing, Peoples R China
[2] 3D Med Inc, Dept Med, Shanghai, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 3, Dept Thorac Surg, Chongqing, Peoples R China
关键词
D O I
10.1016/j.annonc.2020.08.1722
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1408P
引用
收藏
页码:S891 / S891
页数:1
相关论文
共 50 条
[31]   Differential crizotinib efficacy among ROS1 fusion partners in ROS1-positive non-small cell lung cancer. [J].
Lu, Shun ;
Li, Ziming .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[32]   Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition [J].
Jessica J. Lin ;
Adam Langenbucher ;
Pranav Gupta ;
Satoshi Yoda ;
Isobel J. Fetter ;
Marguerite Rooney ;
Andrew Do ;
Marina Kem ;
Kylie Prutisto Chang ;
Audris Y. Oh ;
Emily Chin ;
Dejan Juric ;
Ryan B. Corcoran ;
Ibiayi Dagogo-Jack ;
Justin F. Gainor ;
James R. Stone ;
Jochen K. Lennerz ;
Michael S. Lawrence ;
Aaron N. Hata ;
Mari Mino-Kenudson ;
Alice T. Shaw .
npj Precision Oncology, 4
[33]   ROS1 fusion-positive non-small cell lung cancer-repotrectinib as a new treatment option [J].
Rothschild, Sacha I. ;
Mauti, Laetitia A. .
TRANSLATIONAL CANCER RESEARCH, 2025, 14 (06) :3272-3276
[34]   Mechanisms of resistance to tyrosine kinase inhibitor treatments in patients with ROS1 fusion-positive non-small cell lung cancer [J].
Wang, Jialei ;
Zhao, Xinmin ;
Zhang, Xin ;
Chen, Hanlin ;
Bao, Hairong ;
Wu, Xianghua ;
Wang, Huijie ;
Bao, Hua ;
Pang, Jiao ;
Wang, Sha ;
Tang, Haimeng ;
Tang, Shiting ;
Wu, Xue ;
Shao, Yang .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[35]   Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case report [J].
Wu, Chi-Hao ;
Su, Po-Lan ;
Hsu, Che-Wei ;
Chu, Chang-Yao ;
Lin, Chien-Chung .
THORACIC CANCER, 2021, 12 (22) :3068-3071
[36]   Clinical and Molecular Characteristics of small-scale ROS1 aberrations in non-small cell lung cancer patients [J].
Glaser, Moritz ;
Von Levetzow, Cornelia ;
Michels, Sebastian ;
Nogova, Lucia ;
Katzenmeier, Marianna ;
Woempner, Claudia ;
Schmitz, Jaqueline ;
Bitter, Elisabeth ;
Terjung, Inken ;
Passmann, Elke ;
Schaufler, Diana ;
Eisert, Anna ;
Fischer, Rieke ;
Riedel, Richard ;
Weber, Jan-Phillip ;
Hahne, Sabine ;
Merkelbach-Bruse, Sabine ;
Buettner, Reinhard ;
Wolf, Juergen ;
Scheffler, Matthias .
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) :161-161
[37]   ROS1 aberrations in non-small cell lung cancer patients without rearrangements: Clinical and molecular characteristics [J].
Glaser, M. ;
von Levetzow, C. ;
Michels, S. ;
Nogova, L. ;
Katzenmeier, M. ;
Woempner, C. ;
Schmitz, J. ;
Bitter, E. ;
Terjung, I. ;
Passmann, E. ;
Schaufler, D. ;
Eisert, A. ;
Fischer, R. ;
Riedel, R. ;
Weber, J-P. ;
Hahne, S. ;
Merkelbach-Bruse, S. ;
Buettner, R. ;
Wolf, J. ;
Scheffler, M. .
ANNALS OF ONCOLOGY, 2022, 33 :S56-S57
[38]   Detection of ALK, RET, ROS1 Rearrangements by NanoString in Brazilian Patients with Non-small Cell Lung Cancer [J].
Novaes, L. ;
de Paula, F. ;
Evangelista, A. ;
Mattos, L. ;
De Marchi, P. ;
Silva, C. ;
Ferro, L. ;
Reis, R. M. .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06) :986-986
[39]   Efficacy and safety of crizotinib in patients with ROS1 rearranged non-small cell lung cancer: a retrospective analysis [J].
Masuda, Ken ;
Fujiwara, Yutaka ;
Shinno, Yuki ;
Mizuno, Takaaki ;
Sato, Jun ;
Morita, Ryo ;
Matsumoto, Yuji ;
Murakami, Shuji ;
Goto, Yasushi ;
Kanda, Shintaro ;
Horinouchi, Hidehito ;
Yamamoto, Noboru ;
Ohe, Yuichiro .
JOURNAL OF THORACIC DISEASE, 2019, 11 (07) :2965-2972
[40]   ROS1 gene rearrangement and copy number gain in non-small cell lung cancer [J].
Jin, Yan ;
Sun, Ping-Li ;
Kim, Hyojin ;
Park, Eunhyang ;
Shim, Hyo Sup ;
Jheon, Sanghoon ;
Kim, Kwhanmien ;
Lee, Choon-Taek ;
Chung, Jin-Haeng .
VIRCHOWS ARCHIV, 2015, 466 (01) :45-52